| 000 | 02697 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250516111612.0 | ||
| 264 | 0 | _c20121219 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2012.42.5355 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmoll, Hans-Joachim | |
| 245 | 0 | 0 |
_aCediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III). _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cOct 2012 |
||
| 300 |
_a3588-95 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aBevacizumab |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLeucovorin _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xpathology |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xtherapeutic use |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aCunningham, David | |
| 700 | 1 | _aSobrero, Alberto | |
| 700 | 1 | _aKarapetis, Christos S | |
| 700 | 1 | _aRougier, Philippe | |
| 700 | 1 | _aKoski, Sheryl L | |
| 700 | 1 | _aKocakova, Ilona | |
| 700 | 1 | _aBondarenko, Igor | |
| 700 | 1 | _aBodoky, György | |
| 700 | 1 | _aMainwaring, Paul | |
| 700 | 1 | _aSalazar, Ramon | |
| 700 | 1 | _aBarker, Peter | |
| 700 | 1 | _aMookerjee, Bijoyesh | |
| 700 | 1 | _aRobertson, Jane | |
| 700 | 1 | _aVan Cutsem, Eric | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 30 _gno. 29 _gp. 3588-95 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2012.42.5355 _zAvailable from publisher's website |
| 999 |
_c22093466 _d22093466 |
||